MedPath
NMPA Approval

Reboxetine Mesilate Tablets

国药准字H20051833

August 30, 2020

Drug Information

甲磺酸瑞波西汀片

叶洛抒

片剂

4mg(以C19H23NO3计)

化学药品

August 30, 2020

Company Information

Applicant Company

Manufacturing Company

重庆市渝北区人和镇星光大道100号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸瑞波西汀片 - NMPA 批准文号 | MedPath